临床服务：与NHS合作以实现更好的患者结果

Clinical Services Partnering with the NHS to deliverimproved patient outcomes Who we are IQVIA is a global healthcare data company with a strong presence in theUK and Ireland. We excel in using data, technology, advanced analytics,digital transformation, and clinical research to drive healthcare innovationand productivity, supporting the full system lifecycle. IQVIA works across the entire healthcare ecosystem to support solution development andoptimise patient care, with the ultimate goal of improving patient outcomes, our team workeffectively together with: 95% of NHS organisationsalready use one or more of our services including costing, coding,benchmarking and data warehousing and our insights and feedback expertise is widespread across a rangeof healthcare systems IQVIA is delivering consulting services powered by our own data — using clinical coding analytics, staffsurveys, and PLICS data to pinpoint wheredigital transformation can drive measurable impact IQVIA have delivered theNHS National Staff Survey, surveying over 940,000 people across the NHSWorkforce in 2025 IQVIA specialises in de-risking ourclients’ digital journeysand supporting them with all elements of thesystem lifecycle IQVIA isdelivering the Privacy Enhancing Technology (PET) for the NHS Federated Data Platform (FDP)— the first use case in the NHS of a nationally assured and funded privacy tool to benefit all NHSorganisations — ensuring the highest security standards for patient data management across the NHS IQVIA provideclinical support to over 50% of GP practices & PCNsto enhance NHS capacity, optimisetreatment, and identify patients IQVIA is delivering over20% of all UK commercial clinical trialswith over a third of all of our UK clinicaltrials targeting cancer and its causes Our team We are a patient-centric organisation committed to improving patient experience and clinicaloutcomes across a broad range of therapy areas. Working in close partnership with the NHS and Life Science organisations, we deliver meaningful,measurable impact at scale. As a trusted NHS provider, we deliver services across both primary andsecondary care, giving us deep insight into local and system-wide priorities. Our work is underpinned by insight-driven, end-to-end solutions, designed to support betterhealth outcomes for patients. Clinical pharmacist and nurse-led services Services designed to enhance patient experience and outcomes >400fully employed team of clinical pharmacists, nurses and phlebotomists>100hospitals partnered with IQVIA to deliver services100%ICB Footprint from individual practice support to ICB level Respiratory,including asthma, COPDand spirometry Case study: Improving treatment utilisation andadherence to clinical guidelines in Asthma Background An Integrated Care System (ICS) was interested in improving treatment utilisation and adherence to clinicalguidelines amongst asthma patients at risk of poor clinical outcomes. Poor asthma control can adverselyimpact exacerbations, quality of life as well as unplanned primary care & hospital encounters. Solution Reviews followed guidelines by the BritishThoracic Society (BTS) and the NationalInstitute for Health and Care Excellence (NICE). A Quality Improvement programme wasimplemented across 52 practices. IQVIA clinical pharmacists reviewedcurrent symptom control using AsthmaControl Test (ACT), discussed treatmentregimen compliance and explorednon-pharmacological support, suchas smoking cessation, weight loss,exercise, respiratory hygiene etc. Criteria used to prioritise asthma patientsfor review included: •>=6 Short-Acting Beta-Agonists (SABAs)+ Respiratory hospital admission + >=1course of oral steroids all in last 12m•Receipt of single component Long-ActingBeta-Agonist (LABA) therapy. Results ~18kasthma patientswere prioritised ~16k virtual clinical consultations wereprovided over 16 weeks ~78% of patients agreedor strongly agreedthat speaking with apharmacist helpedthem better use theirasthma medicationsand inhalers 61%of patientsreceived apharmacologicalintervention Compared to last 12m, there was a345% (~5.7k)increase in patients with a recordedPersonal Asthma Action Plan (PAA) Future expansion Building on the above success, IQVIA are now planning an ambitious roll-out of an asthmapopulation health tool as part of the IQVIA Healthcare Analytics Network (IHAN), a primary carenetwork covering many millions of patients. This will enable precision targeting of poorly controlled asthma patients, post-interventionmonitoring and ability to flag non-responsive and / or non-compliant patients for follow-up. Testimonials “We have found this COPD service to be a valuable addition to our patient care offer, providing high-qualityspecialist input that complements our in-house clinical team. The reviews and recommendations provided areclear, clinically appropriate, and easy to integrate into ongoing patient management.” “The service supports us in identifyin